Today: 7 February 2026
Subscribe
Browse Category

LSE:HLN News 4 December 2025 - 6 February 2026

Haleon shares close higher in London as investors turn to Feb. 25 results

Haleon shares close higher in London as investors turn to Feb. 25 results

Haleon shares rose 2% to 379 pence Friday, outperforming the London market as the FTSE 100 logged a seventh straight monthly gain. About 14.1 million Haleon shares traded between 371.1 and 379.3 pence. The company will report full-year results on Feb. 25 and plans a major operating overhaul, including a new chief growth officer. GSK also gained 1.3% in London trading.
31 January 2026
·
Haleon share price slips in London as investors wait for the next big update

Haleon share price slips in London as investors wait for the next big update

Haleon shares dipped 0.1% to 361.8 pence in early London trading Friday after a 1.1% drop Thursday, with about 1 million shares changing hands. The move follows a recent reorganisation announcement as investors await full-year results on Feb. 25. European stocks also edged lower, pressured by a 1% decline in mining shares. Haleon has not issued new regulatory news since early January.
16 January 2026
·
Haleon stock today: shares slip as JD Health China deal lands and Deutsche Bank turns bearish

Haleon stock today: shares slip as JD Health China deal lands and Deutsche Bank turns bearish

Haleon shares fell 0.5% to 364.5 pence in early London trading after Deutsche Bank downgraded the stock to “sell” and cut its price target to 340 pence. JD Health and Haleon announced a new deal to expand their partnership in China beyond chronic disease management. Investors await Haleon’s full-year results on Feb. 25. Financial terms of the China deal were not disclosed.
15 January 2026
·
Haleon PLC stock slides on operating model shake-up as investors look to Feb. 25 results

Haleon PLC stock slides on operating model shake-up as investors look to Feb. 25 results

Haleon shares fell 1.18% to 367.50p Friday after announcing a major operating overhaul, splitting its EMEA and Latin America regions and creating a standalone India Subcontinent unit. New senior roles include Filippo Lanzi as Chief Growth Officer and Björn Timelin as Chief Transformation Officer. The changes are set for mid-2026. Haleon’s market value stands at about £32.7 billion.
10 January 2026
··
Haleon PLC stock edges lower after executive share-deal filing, with earnings in focus

Haleon PLC stock edges lower after executive share-deal filing, with earnings in focus

Haleon shares fell 0.4% to 375.2 pence in early London trading after two senior executives disclosed small share purchases under the company’s reward plan. The transactions, involving 34 partnership shares each by the general counsel and chief marketing officer, were filed Tuesday. Investors are now looking ahead to Haleon’s full-year results and 2026 guidance on Feb. 25.
7 January 2026
··
Haleon PLC (HLN) News Today, 17 December 2025: Shares Rise as Investors Digest Morgan Stanley “Top Pick” Call and Incoming Board Changes

Haleon PLC (HLN) News Today, 17 December 2025: Shares Rise as Investors Digest Morgan Stanley “Top Pick” Call and Incoming Board Changes

Haleon PLC (LSE/NYSE: HLN) closed higher on 17 December 2025, rebounding after Tuesday’s dip. Here’s what’s moving the consumer-health giant behind Sensodyne, Panadol and Advil, including a Morgan Stanley upgrade, leadership changes effective 1 January 2026, and the next key date on the company calendar. Haleon PLC (HLN), the consumer health company behind household brands such as Sensodyne, Panadol, Advil, Centrum, Voltaren and Theraflu, ended Wednesday’s session higher in London, as investors balanced near-term market noise against a string of “positioning” catalysts that have kept the stock in focus into year-end. London South East+2Hargreaves Lansdown+2 While there was no new
17 December 2025
·
Haleon PLC (HLN) Stock on December 4, 2025: Price, Latest News, Analyst Targets and 2026 Outlook

Haleon PLC (HLN) Stock on December 4, 2025: Price, Latest News, Analyst Targets and 2026 Outlook

Updated: December 4, 2025 Haleon PLC – the consumer‑health group behind Sensodyne, Voltaren, Advil, Panadol and Centrum – is ending 2025 in a strangely paradoxical place: the business is grinding out steady growth and strong cash flow, while the share price has been drifting lower in recent weeks. As of early trading on December 4, 2025, Haleon’s New York‑listed ADR (NYSE: HLN) is changing hands around $9.5 per share, implying a market cap in the mid‑$40 billion range. MarketBeat On the London Stock Exchange (LSE: HLN), the stock closed at £3.61 on Wednesday, December 3, down 2.09% on the day
4 December 2025
·

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
New York, Feb 7, 2026, 11:36 EST — Market closed. Home Depot (HD.N) shares rose about 0.7% on Friday to close at $385.15, after trading between $379.10 and $386.37. (Yahoo Finance) The next move may not come from Home Depot itself. A delayed U.S. jobs report is due on Wednesday and the Consumer Price Index (CPI), a key inflation gauge, follows on Friday, after a brief government shutdown pushed both releases back, a Reuters Week Ahead column said. (Reuters) That matters for housing-linked names because interest-rate bets can shift quickly when hiring or inflation surprises. Federal Reserve Vice Chair Philip
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop